Form D · Other Health Care
RESPONSE BIOMEDICAL CORP
Vancouver, A1 · CIK 0000806888
Offering snapshot reported Oct 15, 2013 · SEC filing
- Reported sold
- $3.12M Offering amount: $4M
- Investors reported
- 10 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 26, 2013 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 15, 2013 | Initial | $3,119,136 | No comparison | 10 | SEC filing |
| Jan 6, 2012 | Initial | $4,937,100 | No comparison | 7 | SEC filing |
| Dec 1, 2011 | Initial | $265,238 | No comparison | 3 | SEC filing |
| Aug 12, 2010 | Initial | $7,724,990 | No comparison | 3 | SEC filing |
| May 25, 2010 | Initial | Yet to sell | No comparison | 0 | SEC filing |
| May 29, 2009 | Initial | $3,918,726 | No comparison | Not reported | SEC filing |
| Nov 12, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 16, 2008 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Dec 21, 2006 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Apr 14, 2006 | Paper | Not reported | No comparison | Not reported | |
| Apr 14, 2006 | Paper | Not reported | No comparison | Not reported | |
| Aug 31, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
| Jan 11, 2005 | Paper | Not reported | No comparison | Not reported | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06c
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $74.3K
- Finders' fees
- $0
- Form D file number
- 021-204485
Amounts listed are in Canadian dollars
Cash Commission: $30,957; Warrant Commission*: $43,338. *17,689 warrants to purchase common shares @$2.45 per share. Amounts listed are in Canadian Dollars
Source: Form D, filed Oct 15, 2013. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| William J. Adams | Executive |
| Richard J. Bastiani | Director |
| Richard K. Bear | Director |
| Paul Harris | Executive |
| Anthony F. Holler | Director |
| Dr. Anthony F. Holler | Director |
| Livleen Kaler | Executive |
| S. Wayne Kay | Director, Executive |
| Joseph D. Keegan | Director |
| Dr. Joseph D. Keegan | Director |
| Duane A. Morris | Executive |
| Todd R. Patrick | Director |
| Jeffrey L. Purvin | Director, Executive |
| Clinton H. Severson | Director |
| Clint Severson | Director |
| Lewis Shuster | Director |
| Dr. Peter A. Thompson | Director, Executive |
| Peter A. Thompson | Director |
| Anastasios Tsonis | Executive |
| Dr. David Wang | Director |
| Jonathan Wang | Director |
| David Wang | Director |
| Ian A. Webb | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
1781 75 Th Avenue W.
Vancouver, A1, V6P6P2
Vancouver, A1, V6P6P2